Fluid shear stress sensitizes cancer cells to receptor-mediated apoptosis via trimeric death receptors

New Journal of Physics

Volumn 15, Issue , 2013, Pages

  Mitchell, Michael J ^a   King, Michael R ^a  

^a Cornell University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC; CANCER CELLS; CANCER METASTASIS; CASPASES; CIRCULATING TUMOR CELLS; CONE AND PLATE; DEATH-RECEPTOR; DISTAL LOCATIONS; DOXORUBICIN; FLUID SHEAR STRESS; HUMAN COLON CANCER; NATURAL KILLER CELLS; PATIENT PROGNOSIS; PHYSIOLOGICAL FLUIDS; PROSTATE CANCERS; SHEAR FORCE; STRESS-INDUCED; TIME-DEPENDENT; TUMOR NECROSIS FACTORS;

DIAGNOSIS; DISEASES; LIGANDS; PATHOLOGY;

CELL DEATH;

EID: 84873314188     PISSN: 13672630     EISSN: None     Source Type: Journal    
DOI: 10.1088/1367-2630/15/1/015008     Document Type: Article

References (51)

1. Chaffer C L and Weinberg R A 2011 A perspective on cancer cell metastasis Science 331 1559-64
2. Chambers A F et al 1995 Steps in tumor metastasis: new concepts from intravital microscopy Cancer Metastasis Rev. 14 279-301 (Pubitemid 26027931)
3. Springer T A 1994 Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm Cell 76 301-14 (Pubitemid 24046692)
4. Coussens L M and Werb Z 2002 Inflammation and cancer Nature 420 860-7 (Pubitemid 36019639)
5. Mehlen P and Puisieux A 2006 Metastasis: a question of life or death Nature Rev. Cancer 6 449-58
6. MacDonald I C, Groom A C and Chambers A F 2002 Cancer spread and micrometastasis development: quantitative approaches for in vivo models Bioessays 24 885-93 (Pubitemid 35180844)
7. Li J and King M R 2012 Adhesion receptors as therapeutic targets for circulating tumor cells Frontiers Oncol. 2 79
8. Hughes A D, Mattison J, Western L T, Powderly J D, Greene B T and King M R 2012 Microtube device for selectin-mediated capture of viable circulating tumor cells from blood Clin. Chem. 58 846-53
9. Greene B T, Hughes A D and King M R 2012 Circulating tumor cells: the substrate of personalized medicine? Frontiers Oncol. 2 69
10. Mitchell M J, Chen C S, Ponmudi V, Hughes A D and King M R 2012 E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells J. Control. Release 160 609-17
11. Rana K, Reinhart-King C A and King M R 2012 Inducing apoptosis in rolling cancer cells: a combined therapy with aspirin and immobilized TRAIL and E-selectin Mol. Pharm. 9 2219-27
12. Pitti R M, Marsters S A, Ruppert S, Donahue C J, Moore A and Ashkenazi A 1996 Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J. Biol. Chem. 271 12687-90 (Pubitemid 26175834)
13. Rana K, Liesveld J L and King M R 2009 Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin Biotechnol. Bioeng. 102 1692-702
14. Plasilova M et al 2002 TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors Leukemia 16 67-73 (Pubitemid 34105601)
15. Ashkenazi A 2002 Targeting death and decoy receptors of the tumour-necrosis factor superfamily Nature Rev. Cancer 2 420-30 (Pubitemid 37328939)
16. Smyth M J, Hayakawa Y, Takeda K and Yagita H 2002 New aspects of natural killer cell surveillance and therapy of cancer Nature Rev. Cancer 2 850-61 (Pubitemid 37328903)
17. Cretney E, Takeda K, Yagita H, Glaccum M, Peschon J J and Smyth M J 2002 Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice J. Immunol. 168 1356-61 (Pubitemid 34094506)
18. Takeda K et al 2001 Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells Nature Med. 7 94-100 (Pubitemid 32095647)
19. Smyth M J et al 2001 Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis J. Exp. Med. 193 661-70 (Pubitemid 32524460)
20. Dafni H, Israely T, Bhujwalla Z M, Benjamin L E and Neeman M 2002 Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple labeled albumin Cancer Res. 62 6731-9 (Pubitemid 35364145)
21. Swartz M A and Lund A W 2012 Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity Nature Rev. Cancer 12 210-9
22. Ahamed J, Burg N, Yoshinaga K, Janczak C A, Rifkin D B and Coller B S 2008 In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor- β1 Blood 112 3650-60
23. Qazi H, Shi Z D and Tarbell J M 2011 PLoS one: fluid shear stress regulates the invasive potential of glioma cells via modulation of migratory activity and matrix metalloproteinase expression PLoS One 6 e20348
24. Pedersen J A, Boschetti F and Swartz M A 2007 Effects of extracellular fiber architecture on cell membrane shear stress in a 3D fibrous matrix J. Biomech. 40 1484-92 (Pubitemid 46628685)
25. Turitto V T 1982 Blood viscosity, mass transport and thrombogenesis Prog. Hemost. Thromb. 6 139-77
26. Fidler I J, Yano S, Zhang R D, Fujimaki T and Bucana C D 2002 The seed and soil hypothesis: vascularisation and brain metastases Lancet Oncol. 3 53-7 (Pubitemid 34121146)
27. Burdick M M, McCaffery J M, Kim Y S, Bochner B S and Konstantopoulos K 2003 Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow Am. J. Phys. Cell Physiol. 284 C977-87
28. Wirtz D, Konstantopoulos K and Searson P C 2011 The physics of cancer: the role of physical interactions and mechanical forces in metastasis Nature Rev. Cancer 11 512-22
29. Mitchell M J and King M R 2012 Shear-induced resistance to neutrophil activation via the formyl peptide receptor Biophys. J. 102 1804-14
30. Herbeuval J P et al 2003 Macrophages from cancer patients: analysis of TRAIL, TRAIL receptors and colon tumor cell apoptosis J. Natl Cancer Inst. 95 611-21
31. Kim M B and Sarelius I H 2003 Distributions of wall shear stress in venular convergences of mouse cremaster muscle Microcirculation 10 167-78 (Pubitemid 39004245)
32. Young R C, Ozols R F and Myers C E 1981 The anthracycline antineoplastic drugs New Engl. J. Med. 305 139-53 (Pubitemid 11073081)
33. Osheroff N, Corbett A H and Robinson M J 1994 Mechanism of action of topoisomerase II-targeted antineoplastic drugs Adv. Pharmacol. 29 105-26
34. Thornberry N A and Lazebnik Y L 1998 Caspases: enemies within Science 281 1312-6 (Pubitemid 28406817)
35. Kim K M, Song J J, An J Y, Kwon Y T and Lee Y J 2005 Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression J. Biol. Chem. 280 41047-56 (Pubitemid 41780600)
36. Fulda S and Debatin K M 2006 5-Aza-2′-deoxycytidine and IFN-γ cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8 Oncogene 25 5125-33 (Pubitemid 44285981)
37. Fulda S, Wick W, Weller M and Debatin K M 2002 Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo Nature Med. 8 808-15
38. Kemp T J, Kim J S, Crist S A and Griffith T S 2003 Induction of necrotic tumor cell death by TRAIL/Apo-2L Apoptosis 8 587-99 (Pubitemid 37411743)
39. Holler N et al 2000 Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule Nature Immunol. 1 489-95
40. Meurette O et al 2007 TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions Cancer Res. 67 218-26 (Pubitemid 46142778)
41. Meurette O, Huc L, Rebillard A, Le Moigne G, Lagadic-Gossmann D and Dimanche-Boitrel M-T 2005 TRAIL (TNF-related apoptosis-inducing ligand) induces necrosis-like cell death in tumor cells at acidic extracellular pH Ann. N.Y. Acad. Sci. 1056 379-87 (Pubitemid 43030993)
42. Rutkowski J M and Swartz M A 2007 A driving force for change: interstitial flow as a morphoregulator Trends Cell Biol. 17 44-50 (Pubitemid 46027589)
43. Arlt A et al 2001 Inhibition of NF- κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin Oncogene 20 859-68 (Pubitemid 32198179)
44. Li S, Zhou Y, Wang R, Zhang H, Dong Y and Ip C 2007 Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates Mol. Cancer Therapeutics 6 1031-8 (Pubitemid 46554573)
45. Koblish H K et al 2006 Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo Mol. Cancer Therapeutics 5 160-9
46. Ashkenazi A et al 1999 Safety and antitumor activity of recombinant soluble Apo2 ligand J. Clin. Invest. 104 155-62
47. Quast S A, Berger A, Buttstädt N, Friebel K, Schönherr R and Eberle J 2012 General sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMAC PLoS One 7 e39290
48. Norberg E, Orrenius S and Zhivotovsky B 2010 Mitochondrial regulation of cell death: processing of apoptosis-inducing factor (AIF) Biochem. Biophys. Res. Commun. 396 95-100
49. Stagni V, Mingardi M, Santini S, Giaccari D and Barilà D 2010 ATM kinase activity modulates cFLIP protein levels: potential interplay between DNA damage signalling and TRAIL-induced apoptosis Carcinogenesis 31 1956-63
50. Garimella S V, Rocca A and Lipkowitz S 2012 WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosis Mol. Cancer Res. 10 75-85
51. Suliman A, Lam A, Datta R and Srivastava R K 2001 Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways Oncogene 20 2122-33 (Pubitemid 32424006)